Department of Cardiology, Academic Medical Center, Amsterdam, The, Netherlands.
Am J Med Genet A. 2013 Jul;161A(7):1628-37. doi: 10.1002/ajmg.a.35973. Epub 2013 May 21.
For adult patients with congenital heart disease (CHD), knowledge about the origin and inheritance of their CHD is important. Clinical geneticists may play a significant role in their care. We explored the diagnostic yield of clinical genetic consultation of adult CHD patients, patients' motivations for the consultation, implications for reproductive decisions, patients' evaluation of the impact of provided information, and satisfaction with counseling. Chart review was performed on all adult patients referred for CHD to our clinical genetics department between 2000 and 2011 (n = 90). Additionally, a questionnaire was sent to those patients referred between 2005 and 2011 (n = 64), of which 46 useful questionnaires were returned (72% response). Of patients without an etiological diagnosis at referral (n = 83), 17 (20%) were eventually diagnosed with syndromic CHD, 6 (7%) with nonsyndromic monogenetic CHD and 45 (54%) with nonsyndromic multifactorial CHD. The diagnosis remained undetermined in 15 (18%) patients. Half of patients who returned the questionnaire had purposefully postponed having children until after genetic consultation and 13% had changed their mind about having children or not after the consultation. Counseling was valued positively. In this study, we showed the added value of clinical genetic consultation in the care for adult CHD patients: it improves diagnostics by establishing an etiological diagnosis and associated recurrence risk in a substantial proportion of patients and leads to more informed reproductive decisions. With new genetic testing technologies an etiological diagnosis may be established in an increasing number of patients in the near future.
对于患有先天性心脏病(CHD)的成年患者,了解其 CHD 的起源和遗传方式非常重要。临床遗传学家可能在他们的治疗中发挥重要作用。我们探讨了成年 CHD 患者临床遗传咨询的诊断效果、患者咨询的动机、对生殖决策的影响、患者对所提供信息的影响的评估,以及对咨询的满意度。我们对 2000 年至 2011 年间转诊到我们临床遗传学部门的所有成年 CHD 患者进行了图表回顾(n = 90)。此外,我们还向 2005 年至 2011 年间转诊的患者发送了一份问卷(n = 64),其中 46 份有用的问卷得到了回复(72%的回复率)。在转诊时没有病因诊断的患者(n = 83)中,17 例(20%)最终被诊断为综合征性 CHD,6 例(7%)为非综合征性单基因 CHD,45 例(54%)为非综合征性多因素 CHD。15 例(18%)患者的诊断仍未确定。返回问卷的患者中有一半是有目的地推迟生育,直到遗传咨询后才生育,13%的患者在咨询后改变了生育或不生育的想法。咨询受到了积极的评价。在这项研究中,我们展示了临床遗传咨询在成年 CHD 患者护理中的附加价值:它通过在相当一部分患者中建立病因诊断和相关的复发风险,改善了诊断,并导致更明智的生殖决策。随着新的基因检测技术的出现,在不久的将来,可能会有越来越多的患者能够建立病因诊断。